The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host-Pathogen Interactions.
galectin-3
host–pathogen interactions
inflammation
therapeutic target
viral infection
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
01 Jun 2023
01 Jun 2023
Historique:
received:
07
05
2023
revised:
29
05
2023
accepted:
29
05
2023
medline:
12
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Galectin-3 (Gal-3), a beta-galactoside-binding lectin, plays a pivotal role in various cellular processes, including immune responses, inflammation, and cancer progression. This comprehensive review aims to elucidate the multifaceted functions of Gal-3, starting with its crucial involvement in viral entry through facilitating viral attachment and catalyzing internalization. Furthermore, Gal-3 assumes significant roles in modulating immune responses, encompassing the activation and recruitment of immune cells, regulation of immune signaling pathways, and orchestration of cellular processes such as apoptosis and autophagy. The impact of Gal-3 extends to the viral life cycle, encompassing critical phases such as replication, assembly, and release. Notably, Gal-3 also contributes to viral pathogenesis, demonstrating involvement in tissue damage, inflammation, and viral persistence and latency elements. A detailed examination of specific viral diseases, including
Identifiants
pubmed: 37298569
pii: ijms24119617
doi: 10.3390/ijms24119617
pmc: PMC10253520
pii:
doi:
Substances chimiques
Galectin 3
0
Galectins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Sci Rep. 2023 Jan 26;13(1):1460
pubmed: 36702907
Eur J Pharmacol. 2014 Sep 5;738:125-32
pubmed: 24877694
Int J Mol Sci. 2023 Apr 22;24(9):
pubmed: 37175392
Mol Immunol. 2015 Dec;68(2 Pt A):194-202
pubmed: 26355912
Viruses. 2021 Nov 27;13(12):
pubmed: 34960648
Pharmaceuticals (Basel). 2021 May 20;14(5):
pubmed: 34065500
Int J Mol Sci. 2021 May 13;22(10):
pubmed: 34067978
Biomark Res. 2023 Feb 22;11(1):22
pubmed: 36814341
Int J Mol Sci. 2022 Jul 26;23(15):
pubmed: 35897786
Glycobiology. 1999 Apr;9(4):383-7
pubmed: 10089212
Cancer Metastasis Rev. 2018 Mar;37(1):107-124
pubmed: 29243000
Nat Rev Microbiol. 2004 Feb;2(2):109-22
pubmed: 15043007
Vaccines (Basel). 2023 Mar 25;11(4):
pubmed: 37112643
Adv Exp Med Biol. 2012;946:21-36
pubmed: 21948360
J Biol Chem. 2013 Sep 27;288(39):28398-408
pubmed: 23926108
Biochemistry. 2016 Aug 16;55(32):4541-51
pubmed: 27427828
J Gen Virol. 2019 Mar;100(3):333-349
pubmed: 30648945
Philos Trans R Soc Lond B Biol Sci. 2012 Oct 19;367(1604):2864-71
pubmed: 22966141
Clin Exp Med. 2023 Feb;23(1):151-155
pubmed: 35076790
Virol J. 2022 May 26;19(1):92
pubmed: 35619180
J Bioenerg Biomembr. 2007 Feb;39(1):79-84
pubmed: 17318396
Food Chem Toxicol. 2019 Dec;134:110827
pubmed: 31542433
Beni Suef Univ J Basic Appl Sci. 2022;11(1):78
pubmed: 35730010
Glycobiology. 2010 May;20(5):521-32
pubmed: 20040515
F1000Res. 2020 Sep 1;9:1078
pubmed: 33082935
BMC Cancer. 2018 May 22;18(1):580
pubmed: 29788922
Front Cell Neurosci. 2022 Oct 05;16:949079
pubmed: 36274989
Rev Endocr Metab Disord. 2022 Jun;23(3):569-577
pubmed: 35083706
FEBS Lett. 2003 May 22;543(1-3):61-5
pubmed: 12753906
Virol J. 2021 Feb 17;18(1):36
pubmed: 33596956
Front Immunol. 2018 Dec 04;9:2839
pubmed: 30564237
Glycobiology. 2014 Nov;24(11):1022-35
pubmed: 24996823
J Microbiol Immunol Infect. 2020 Dec;53(6):925-935
pubmed: 31630962
Am J Pathol. 2018 Apr;188(4):1031-1042
pubmed: 29366678
Virology. 2014 Nov;468-470:150-159
pubmed: 25173091
Front Pharmacol. 2022 Jan 05;12:805535
pubmed: 35069217
Adv Exp Med Biol. 2020;1204:141-167
pubmed: 32152946
PLoS Pathog. 2020 Aug 4;16(8):e1008741
pubmed: 32750085
Front Immunol. 2020 Aug 18;11:2069
pubmed: 32973815
J Mol Biol. 2014 Apr 3;426(7):1439-51
pubmed: 24326249
Virology. 2015 Jul;481:63-72
pubmed: 25768892
Int J Mol Sci. 2022 Jun 30;23(13):
pubmed: 35806317
Oncotarget. 2017 Apr 18;8(16):27569-27581
pubmed: 28187438
Glycobiology. 2016 Feb;26(2):155-65
pubmed: 26447186
J Microbiol Immunol Infect. 2018 Dec;51(6):829-838
pubmed: 30196007
Med Sci Monit. 2015 May 13;21:1376-80
pubmed: 25968249
Int J Mol Sci. 2023 May 01;24(9):
pubmed: 37175823
Am J Respir Crit Care Med. 2023 Jan 15;207(2):118-120
pubmed: 36154818
Am J Respir Crit Care Med. 2012 Mar 1;185(5):537-46
pubmed: 22095546
Int J Mol Sci. 2020 Apr 21;21(8):
pubmed: 32326345
Viruses. 2019 Apr 16;11(4):
pubmed: 31014029
Cytogenet Cell Genet. 1995;69(3-4):223-5
pubmed: 7698018
Sci Rep. 2022 Feb 3;12(1):1856
pubmed: 35115644
J Virol. 2011 Sep;85(18):9506-16
pubmed: 21752913
Cell. 2016 Nov 3;167(4):973-984.e12
pubmed: 27814523
Int J Mol Sci. 2018 Jan 26;19(2):
pubmed: 29373564
Curr Opin HIV AIDS. 2017 Jan;12(1):47-56
pubmed: 27662501
Pain. 2012 Mar;153(3):585-592
pubmed: 22197693
Biochem Biophys Res Commun. 2008 Aug 22;373(2):206-12
pubmed: 18555795
PLoS Pathog. 2019 Aug 12;15(8):e1008002
pubmed: 31404116
iScience. 2018 Nov 30;9:101-119
pubmed: 30388704
EBioMedicine. 2021 Aug;70:103525
pubmed: 34392148
Pathogens. 2020 May 29;9(6):
pubmed: 32485969
Front Mol Biosci. 2021 Jun 07;8:666756
pubmed: 34164431
Mol Immunol. 2015 May;65(1):1-16
pubmed: 25597246
Sci Rep. 2021 Feb 12;11(1):3718
pubmed: 33580170
Viruses. 2022 May 16;14(5):
pubmed: 35632805
J Gastrointestin Liver Dis. 2022 Dec 17;31(4):444-452
pubmed: 36535063
Sci Rep. 2017 Nov 1;7(1):14787
pubmed: 29093555
Dis Markers. 2017;2017:6275987
pubmed: 28487598
Int J Mol Sci. 2018 Mar 19;19(3):
pubmed: 29562695
Int J Mol Sci. 2022 Oct 29;23(21):
pubmed: 36361933
Am J Respir Crit Care Med. 2023 Jan 15;207(2):138-149
pubmed: 35972987
Microbes Infect. 2003 Nov;5(13):1263-77
pubmed: 14623023
Pain Res Manag. 2020 Apr 14;2020:8730918
pubmed: 32351643
Virus Res. 2019 Jan 15;260:86-93
pubmed: 30481548
Microb Pathog. 2021 Apr;153:104799
pubmed: 33609650
J Intern Med. 2009 Jan;265(1):78-96
pubmed: 19093962
FEBS J. 2017 Jan;284(1):97-113
pubmed: 27981746
Biomolecules. 2021 Aug 01;11(8):
pubmed: 34439802
Int J Mol Sci. 2022 Sep 07;23(18):
pubmed: 36142255
Clin Lab. 2022 Dec 1;68(12):
pubmed: 36546745
Cytokine. 2022 Oct;158:155970
pubmed: 35917725
J Virol. 2013 May;87(10):5841-7
pubmed: 23487460
Front Microbiol. 2019 Feb 08;10:185
pubmed: 30800112
J Biomed Sci. 2023 Feb 23;30(1):14
pubmed: 36823664
Int J Mol Sci. 2013 Oct 01;14(10):19891-910
pubmed: 24084731
PeerJ. 2020 Jun 15;8:e9392
pubmed: 32587806
Int J Mol Sci. 2020 Jul 19;21(14):
pubmed: 32707678
Mediators Inflamm. 2017;2017:9247574
pubmed: 28607536
Nat Rev Immunol. 2023 Jan 16;:
pubmed: 36646848
Semin Respir Crit Care Med. 2016 Aug;37(4):586-602
pubmed: 27486739
Oncoimmunology. 2018 Feb 20;7(6):e1434467
pubmed: 29872573
Viruses. 2010 Aug;2(8):1666-1680
pubmed: 21994700
Nat Rev Microbiol. 2009 Jun;7(6):424-38
pubmed: 19444247
Glycobiology. 2022 Aug 18;32(9):760-777
pubmed: 35789267
Biomed Pharmacother. 2021 Jul;139:111713
pubmed: 34243634
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Cancers (Basel). 2021 Sep 09;13(18):
pubmed: 34572756
PLoS One. 2016 Dec 21;11(12):e0168627
pubmed: 28002441
J Immunol. 2010 Dec 1;185(11):7037-46
pubmed: 20980634